BP
Ballentine Partners Portfolio holdings
AUM
$6.64B
1-Year Return
16.37%
This Quarter Return
+2.62%
1 Year Return
+16.37%
3 Year Return
+60.04%
5 Year Return
+90.6%
10 Year Return
+147.86%
AUM
$2.08B
AUM Growth
+$160M
(+8.3%)
Cap. Flow
+$114M
Cap. Flow
% of AUM
5.47%
Top 10 Holdings %
Top 10 Hldgs %
60.32%
Holding
400
New
70
Increased
225
Reduced
57
Closed
9
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$31.5M |
| 2 |
Pfizer
PFE
|
$4.73M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
$4.17M |
| 4 |
Exxon Mobil
XOM
|
$3.55M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$2.78M |
Top Sells
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
$3.5M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
$1.3M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$1.07M |
| 4 |
Vanguard Small-Cap ETF
VB
|
$875K |
| 5 |
iShares MSCI EAFE ETF
EFA
|
$874K |
Sector Composition
| 1 | Technology | 2.4% |
| 2 | Industrials | 2.28% |
| 3 | Financials | 2.13% |
| 4 | Energy | 1.92% |
| 5 | Healthcare | 1.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Antero Midstream
AM
$8.64B
| $568K | 0.03% |
49,578
+11,130
| +29% | +$128K |
|
202
Baxter International
BAX
$12.4B
| $565K | 0.03% |
6,905
+524
| +8% | +$42.9K |
|
203
Booking.com
BKNG
$180B
| $556K | 0.03% |
297
+52
| +21% | +$97.3K |
|
204
Morgan Stanley
MS
$237B
| $556K | 0.03% |
12,707
+6,472
| +104% | +$283K |
|
205
Medtronic
MDT
$119B
| $547K | 0.03% |
5,617
+1,383
| +33% | +$135K |
|
206
Air Products & Chemicals
APD
$64.1B
| $537K | 0.03% |
2,371
-246
| -9% | -$55.7K |
|
207
Charles Schwab
SCHW
$170B
| $509K | 0.02% |
12,678
+1,284
| +11% | +$51.6K |
|
208
Waste Management
WM
$87.9B
| $509K | 0.02% |
4,412
+636
| +17% | +$73.4K |
|
209
Banco Bilbao Vizcaya Argentaria
BBVA
$106B
| $506K | 0.02% |
91,047
+7,013
| +8% | +$39K |
|
210
Charter Communications
CHTR
$35.9B
| $501K | 0.02% |
1,268
+184
| +17% | +$72.7K |
|
211
Technology Select Sector SPDR Fund
XLK
$84.7B
| $496K | 0.02% |
6,362
+1,286
| +25% | +$100K |
|
212
Philip Morris
PM
$253B
| $494K | 0.02% |
6,288
+1,509
| +32% | +$119K |
|
213
Vanguard Mid-Cap Growth ETF
VOT
$17.7B
| $494K | 0.02% |
3,310
| – | – |
|
214
HSBC
HSBC
$229B
| $493K | 0.02% |
11,802
+923
| +8% | +$38.6K |
|
215
Travelers Companies
TRV
$61.7B
| $492K | 0.02% |
3,293
+393
| +14% | +$58.7K |
|
|
CNXM
216
DELISTED
CNX Midstream Partners LP
CNXM
| $487K | 0.02% |
34,630
+10,320
| +42% | +$145K |
|
217
Boston Scientific
BSX
$160B
| $481K | 0.02% |
11,185
+1,974
| +21% | +$84.9K |
|
218
Eli Lilly
LLY
$660B
| $480K | 0.02% |
4,327
+771
| +22% | +$85.5K |
|
219
Diageo
DEO
$59.2B
| $477K | 0.02% |
2,774
-34
| -1% | -$5.85K |
|
220
Vanguard Small-Cap Growth ETF
VBK
$20.5B
| $474K | 0.02% |
2,543
-56
| -2% | -$10.4K |
|
221
Broadcom
AVGO
$1.62T
| $470K | 0.02% |
16,350
+3,720
| +29% | +$107K |
|
222
Biogen
BIIB
$20.7B
| $460K | 0.02% |
1,965
+23
| +1% | +$5.38K |
|
223
Aflac
AFL
$56.7B
| $454K | 0.02% |
8,288
+382
| +5% | +$20.9K |
|
224
Humana
HUM
$37.3B
| $453K | 0.02% |
1,709
-9
| -0.5% | -$2.39K |
|
225
TSMC
TSM
$1.28T
| $453K | 0.02% |
11,568
+1,510
| +15% | +$59.1K |
|